A5083473661- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Heart Failure Treatment and Management
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Neurological disorders and treatments
- Cutaneous Melanoma Detection and Management
- Systemic Sclerosis and Related Diseases
- Cardiomyopathy and Myosin Studies
- Global Health Care Issues
- Medication Adherence and Compliance
- Primary Care and Health Outcomes
- Streptococcal Infections and Treatments
- Medical Imaging and Pathology Studies
- Intravenous Infusion Technology and Safety
- Health Services Management and Policy
- Nonmelanoma Skin Cancer Studies
- Diphtheria, Corynebacterium, and Tetanus
- Irish and British Studies
- 3D Printing in Biomedical Research
- Image Processing and 3D Reconstruction
- Pulmonary Hypertension Research and Treatments
- Pleural and Pulmonary Diseases
Stavanger University Hospital
2014-2024
University of Stavanger
2023-2024
Hypertension pulmonaire : physiopathologie et innovation thérapeutique
2024
Inserm
2024
Université Paris-Saclay
2024
University of Bergen
2016-2020
Institute of Cardiology
2018
Corona (Poland)
2018
Trinity College Dublin
2018
Cégep de l'Outaouais
2006-2008
The Cardiac Resynchronization Therapy (CRT) Survey II is a 6 months snapshot survey initiated by two ESC Associations, the European Heart Rhythm Association and Failure Association, which designed to describe clinical practice regarding implantation of CRT devices in broad sample hospitals 47 member countries. large volume demographic data collected should reflect current patient selection, implantation, follow-up provide information relevant for assessing healthcare resource utilization...
The decision to implant a cardiac resynchronization therapy pacemaker (CRT-P) or defibrillator (CRT-D) may be challenging. There are no clear guideline recommendations as randomized study of (CRT) has been designed compare the effects CRT-P with those CRT-D on patients' outcomes. In CRT Survey II, we studied patient and implantation centre characteristics associated choice vs. CRT-D.Clinical practice data from 10 692 patients undergoing whom 7467 (70%) received 3225 (30%) across 42 ESC...
Cardiac resynchronization therapy (CRT) is effective in heart failure with reduced ejection fraction (HFrEF) and dyssynchrony but underutilized. In a cohort study, we identified clinical, organizational, level of care factors linked to CRT implantation.We included HFrEF patients fulfilling study criteria the ESC-HF-Long Term Registry (ESC-HF-LT, n = 1031), Swedish Heart Failure (SwedeHF) (n 5008), ESC-CRT Survey II 11 088). ESC-HF-LT, 36% had indication which 47% CRT, 53% no remaining 54%...
The goal of the 1-year observational, multicentre, open-label study reported here was to identify factors influencing adherence high-dose interferon alfa-2b adjuvant therapy in patients at high risk recurrence following surgical excision malignant melanoma. carried out 23 tertiary-care centres across Canada.The 225 enrolled all had melanoma that surgically excised and required treatment with alfa-2b. Of these patients, 64% were men. Mean age 51.7 years. All received during a 4-week induction...
Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with heart failure (HF) electrical dyssynchrony. The European Society of Cardiology (ESC) Guidelines provide evidence-based recommendations indicating optimal patient selection for CRT implantation both the 2013 Heart Rhythm Association (EHRA) 2016 Failure (HFA) Guidelines. We assessed adherence to guidelines identified factors associated guideline adherence.In 2016, HFA EHRA conducted Survey II 42 ESC...
Multiple randomised clinical trials have proven that cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in appropriately selected patients with congestive heart failure is recommended for such as per the European Society of Cardiology guidelines.In this paper we compare indications demographics recipients Poland other countries.In 2015 2016, physicians from 42 countries participated second edition Cardiac Resynchronisation Therapy Survey. For 14 months, 288 implanting...
Abstract Aims We aimed to externally validate the SEMMELWEIS-CRT score for predicting 1-year all-cause mortality in European Cardiac Resynchronization Therapy (CRT) Survey I dataset—a large multi-centre cohort of patients undergoing CRT implantation. Methods and results The is a machine learning-based tool trained This demonstrated impressive performance during internal validation but has not yet been validated externally. To this end, we applied it data 1367 from dataset. predicted with an...
Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in selected patients with heart failure (HF) electrical dyssynchrony. This treatment receives class IA recommendations European Society of Cardiology (ESC) guidelines. However, despite these strong recommendations, CRT implantation practice varies greatly Europe. The purpose the sub-analysis Survey II data was to describe how countries' health per capita expenditure affects practice.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Tajstra M, Łasocha D, Gadula-Gacek E, et al. Cardiac resynchronization in Poland – comparable procedural routines? Insights from CRT Survey II. Advances Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2019;15(4):477-484. doi:10.5114/aic.2019.90223. APA Tajstra, M., Łasocha, D., Gadula-Gacek, E., Ostręga, Michalak, L., & Wojciechowski, D. (2019). Interwencyjnej, 15(4), 477-484....
A patient presented with tetanus ten days after blunt trauma a lawn mower. Our case describes the diagnosis and treatment of this an infectious disease commonly seen in developing world but rarely developed world.
Levesque, N.1; Mitchinson, K.2; Lawrie, D.3; Fedorak, L.5; MacDonald, D.4; Normand, C.6; Pouliot, J.7 Author Information
Between October 2015 and December 2016, 11,088 patients from 42 countries having cardiac resynchronisation therapy (CRT) devices implanted were included in the CRT II Survey. We compared characteristics of Swiss recipients with overall European population.Demographic procedural data seven centres recruiting all consecutive undergoing either de-novo implantation or an upgrade to a system collected population.A total 320 (24.4% female, mean age 71.0 ± 10.2 years, 47% ischaemic cardiomyopathy)...
Aims . The Cardiac Resynchronization Therapy (CRT) Survey II was conducted between October 2015 and December 2016 included data from 11088 CRT implantations 42 countries. survey’s aim to report on current European practice. of this study compare the Croatian national practice with data. Methods Five centres Croatia recruited consecutive patients, in a 15-month period, who underwent implantation, primary or an upgrade. Data were collected prospectively by using online database. Results A...